Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

1. Screening for Asymptomatic Carotid Artery Stenosis

Screening for Asymptomatic Carotid Artery Stenosis Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation to see the latest documents available. Recommendation Summary Population Recommendation General Adult Population The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. D View the Clinical Summary in Population Adults without a history of transient ischemic attack (...) , stroke, or other neurologic signs or symptoms Recommendation Do not screen for asymptomatic carotid artery stenosis in the general adult population. Grade: D Risk Assessment The major risk factors for carotid artery stenosis include older age, male sex, hypertension, smoking, hypercholesterolemia, diabetes mellitus, and heart disease. Screening Tests All screening strategies, including ultrasonography with or without confirmatory tests (digital subtraction or magnetic resonance angiography), have

2021 U.S. Preventive Services Task Force

2. Mass screening vs lockdown vs combination of both to control COVID-19: A systematic review Full Text available with Trip Pro

Mass screening vs lockdown vs combination of both to control COVID-19: A systematic review Mass screening vs lockdown vs combination of both to control COVID-19: A systematic review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. National Institutes of Health National Library (...) Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation J Public Health Res Actions . 2020 Dec 18;9(4):2011. doi: 10.4081/jphr.2020.2011. eCollection 2020 Oct 14. Mass screening vs lockdown vs combination of both to control COVID-19: A systematic review , , Affiliations Expand Affiliations 1 Faculty of Medicine, Universitas Indonesia, Jakarta. 2 Southeast Asian Ministers

2021 EvidenceUpdates

3. 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice Full Text available with Trip Pro

2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice - PubMed This site needs JavaScript to work properly. Please enable it to take advantage (...) of print. 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Section for Outcomes Research, Medical University of Vienna, Wien, Austria. 2 Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Wien, Austria. 3 Section for Outcomes Research, Medical University of Vienna, Wien

2021 EvidenceUpdates

4. Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study)

Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study) Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study) - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several (...) the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study) , , , , , , , , , , Affiliations Expand Affiliations 1 Gastroenterology, University of Texas Health Science Center at Houston, Houston, Texas, USA brooks.d.cash@uth.tmc.edu. 2 Gastroenterology, Borland Groover Clinic, Jacksonville, Florida, USA. 3 Specialists in Gastroenterology, Clinical Research Professionals, Saint Louis, Missouri, USA. 4 Gastroenterology and Hepatology, Mayo Clinic

2021 EvidenceUpdates

5. Breast screening: supporting women with learning disabilities

Breast screening: supporting women with learning disabilities Breast screening: supporting women with learning disabilities - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You can at any time. Hide (...) this message Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance Breast screening: supporting women with learning disabilities Information for health professionals to support women with learning disabilities to access breast screening. Published 21 November 2018 Last updated 15 February 2021 — From: Documents Ref: PHE publications gateway number: 2018628 HTML ODT , 547KB This file is in an format This file may not be suitable for users

2021 Public Health England

6. Fetal anomaly screening: 20-week scan

Fetal anomaly screening: 20-week scan Screening in pregnancy: 20-week scan - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You can at any time. Hide this message Show or hide search Search on GOV.UK (...) Search Menu National lockdown: stay at home Check what you need to do Guidance Screening in pregnancy: 20-week scan Information about the screening test that takes place between 18 weeks and 20 weeks 6 days of pregnancy, commonly known as the 20-week scan. Published 7 May 2019 Last updated 15 February 2021 — From: Documents HTML Details This guide to the 20-week scan tells expectant parents: its purpose what the possible results mean what will happen if it cannot be completed It is also available

2021 Public Health England

7. Prevention, Screening, Diagnosis, and Pregnancy Management for Fetal Neural Tube Defects

Prevention, Screening, Diagnosis, and Pregnancy Management for Fetal Neural Tube Defects Guideline No. 410: Prevention, Screening, Diagnosis, and Pregnancy Management for Fetal Neural Tube Defects - Journal of Obstetrics and Gynaecology Canada Go search Please enter a term before submitting your search. , P124-139.e8, January 01, 2021 Powered By Mendeley Share on Guideline No. 410: Prevention, Screening, Diagnosis, and Pregnancy Management for Fetal Neural Tube Defects R. Douglas Wilson (...) Correspondence Corresponding Author : R. Douglas Wilson Affiliations Calgary, AB Tim Van Mieghem Affiliations Toronto, ON Sylvie Langlois Affiliations Vancouver, BC Paige Church Affiliations Toronto, ON Published: November 16, 2020 DOI: ABSTRACT Objective This revised guideline is intended to provide an update on the genetic aspects, prevention, screening, diagnosis, and management of fetal neural tube defects. Target population Women who are pregnant or may become pregnant. Neural tube defect screening

2021 Society of Obstetricians and Gynaecologists of Canada

8. Newborn blood spot screening: care pathway

Newborn blood spot screening: care pathway Newborn blood spot screening: care pathway - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You can at any time. Hide this message Show or hide search (...) Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance Newborn blood spot screening: care pathway This document describes the newborn blood spot (NBS) screening pathway. Published 1 June 2015 Last updated 3 February 2021 — From: Documents HTML Details Contact the if you have any questions about this publication. Published 1 June 2015 Last updated 3 February 2021 3 February 2021 Added accessible version of care pathway for newborn blood spot screening. 20

2021 Public Health England

9. Sickle cell and thalassaemia screening: education and training

Sickle cell and thalassaemia screening: education and training Sickle cell and thalassaemia screening: education and training - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You can at any time (...) . Hide this message Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance Sickle cell and thalassaemia screening: education and training Training and continuing professional development (CPD) for people working in the sickle cell and thalassaemia screening programme in England. Published 8 December 2017 Last updated 4 February 2021 — From: Contents Print this page This guide sets out education and training resources available to healthcare

2021 Public Health England

10. Cervical screening: laboratory HPV testing and cytology services

Cervical screening: laboratory HPV testing and cytology services Cervical screening: laboratory HPV testing and cytology services - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You can at any time (...) . Hide this message Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance Cervical screening: laboratory HPV testing and cytology services Recording and reporting requirements for laboratories in accordance with the primary high risk human papillomavirus (hrHPV) screening pathway. Published 20 September 2019 Last updated 4 February 2021 — From: Documents HTML Details This guidance covers: the pathway for primary 4 February 2021 Added new

2021 Public Health England

11. NHS population screening: education and training

NHS population screening: education and training NHS population screening: education and training - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You can at any time. Hide this message Show or hide (...) search Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance NHS population screening: education and training Resources to support screening professionals in their initial training and continuing professional development (CPD). Published 8 December 2017 Last updated 4 February 2021 — From: Contents Print this page Use this guide to: download tools to help explain screening access e-learning access programme specific training sign up for screening training e

2021 Public Health England

12. Cervical screening: lesbian and bisexual women

Cervical screening: lesbian and bisexual women Cervical screening: lesbian and bisexual women - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You can at any time. Hide this message Show or hide (...) search Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance Cervical screening: lesbian and bisexual women Advice on cervical screening for lesbian and bisexual women. Published 1 September 2009 Last updated 19 January 2021 — From: Documents HTML Details Anyone aged 25 to 64 with a cervix is eligible for cervical screening. This guidance is for lesbian and bisexual women, and includes information on: what screening does where to go for cervical screening

2021 Public Health England

13. Automated Frailty Screening At-Scale for Pre-Operative Risk Stratification Using the Electronic Frailty Index

Automated Frailty Screening At-Scale for Pre-Operative Risk Stratification Using the Electronic Frailty Index Automated Frailty Screening At-Scale for Pre-Operative Risk Stratification Using the Electronic Frailty Index - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. National (...) citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation J Am Geriatr Soc Actions . 2021 Jan 19. doi: 10.1111/jgs.17027. Online ahead of print. Automated Frailty Screening At-Scale for Pre-Operative Risk Stratification Using the Electronic Frailty Index , , , , , , , , , , , , Affiliations Expand Affiliations 1 Section on Gerontology

2021 EvidenceUpdates

14. Extended Interval Screening by the Diabetic RetinaScreen Programme

Extended Interval Screening by the Diabetic RetinaScreen Programme Influenza Vaccination in Children Health Information and Quality Authority Scoping Report Extended Interval Screening by the Diabetic RetinaScreen Programme in Ireland Published: 16 February 2021 Safer Better Care Scoping report: Extended Interval Screening by Diabetic RetinaScreen Programme Health Information and Quality Authority Page 1 of 46 Table of Contents Table of Contents 1 Key points 2 List of abbreviations used (...) in this report 4 1. Introduction 6 1.1. Description 6 2. Scope 9 2.1. Research Question 9 Table 1. Research question outlined in the PICO format 9 3. Literature search 10 4. Potential clinical impact 11 4.1. HTAs 11 Table 2. The modelled number of screening referrals for, and the estimated accuracy of, different screening intervals stratified by patients at low and high risk of retinopathy progression (adapted from Scanlon et al.) (23) 14 4.2. Systematic reviews 16 4.3. Non-systematic reviews 17 4.4

2021 Health Information and Quality Authority

15. Abdominal aorta aneurysm (AAA) screening of men aged 65

Abdominal aorta aneurysm (AAA) screening of men aged 65 Abdominal aorta aneurysm (AAA) screening of men aged 65 - NIPH Search for: Søk Menu To top level Close Infectious diseases & Vaccines Mental & Physical health Environment & Lifestyle Health in Norway Quality & Knowledge Research & Access to data About NIPH Close Abdominal aorta aneurysm (AAA) screening of men aged 65 Order Download: Key message Abdominal aortic aneurysm (AAA) is a weakening of the aortic wall resulting in an abnormal (...) %. In Norway, it is estimated to be around 2.5%. Prevalence among women is one-sixth to one-fourth of that among men. Screening programs for AAA can help to identify patients with a high risk of AAA rupture. Those identified as suitable for repair, usually by ultrasound scan, are offered preventive (elective) surgery to reduce their individual risk of rupture. In Norway, the number of operations (urgent and elective) is approximately 700-800 per year. AAA screening is considered a potentially beneficial

2021 Norwegian Institute of Public Health

16. Mandatory Alcohol Screening

Mandatory Alcohol Screening Canadian Centre on Substance Use and Addiction • Centre canadien sur les dépendances et l’usage de substances Page 1 www.ccsa.ca • www.ccdus.ca Policy Brief June 2020 Mandatory Alcohol Screening This policy brief is one of a series on current topics related to impaired driving in Canada. Other topics include oral fluid drug screening, administrative sanctions and drug per se laws. The briefs are not intended to provide a comprehensive and critical review (...) . Key Considerations • Mandatory alcohol screening (MAS) became law in Canada on December 18, 2018. • MAS allows police officers to demand a breath test from a driver in the absence of having a reasonable suspicion that the driver has alcohol in their body. • MAS has been implemented successfully in many other countries around the world. • MAS, particularly when used in combination with public awareness and enhanced enforcement, offers the most expeditious and effective approach for enhancing

2021 Canadian Centre on Substance Abuse

17. Tobacco screening and treatment for adult cancer patients

Tobacco screening and treatment for adult cancer patients Tobacco Screening and Treatment For Adult Cancer Patients Effective Date: November, 2020 Clinical Practice Guideline SUPP-01 – Version 3 www.ahs.ca/guru Guideline Resource Unit guru@ahs.ca 2 Guideline Resource Unit Last revision: August 2016 Background In 2015, an estimated 17,000 Albertans were diagnosed with cancer and 6,500 people died of it.1 By 2030, approximately 27,000 new cancer cases are projected to occur, representing a 65 (...) % increase since 2010 and a 240% increase since 1990. 2 Smoking is the leading preventable risk factor for cancer and is responsible for an estimated 30% of all cancer-related deaths, as well as the majority of lung (75.6%) and larynx (74.3%) cancers within Alberta. 3,4 Tobacco screening and cessation treatment for cancer patients is a key to high-quality oncology care. An estimated 25 - 80% of individuals who smoke will continue smoking following their diagnosis. 5 Continued tobacco use following

2021 CPG Infobase

18. Oral Fluid Drug Screening

Oral Fluid Drug Screening www.ccsa.ca • www.ccdus.ca March 2020 Policy Brief Canadian Centre on Substance Use and Addiction • Centre canadien sur les dépendances et l’usage de substance Page 1 Policy Brief Oral Fluid Drug Screening Key Considerations • Changes to the Criminal Code of Canada allow police to use approved oral fluid drug screening equipment to test drivers for the presence of cannabis (tetrahydrocannabinol), methamphetamine and/or cocaine. • Screening for drugs in samples of oral (...) fluid (saliva) collected at roadside provides a viable means of enhancing the detection of drug use by drivers. • Oral fluid drug screening equipment will not eliminate the need for the Standardized Field Sobriety Test and the Drug Evaluation and Classification program. The Issue For the past four decades, the police in Canada have had the authority to use approved alcohol screening devices (ASDs) to check drivers for alcohol consumption. These devices are a quick and easy means of obtaining

2021 Canadian Centre on Substance Abuse

19. Mapping of methods to increase participation in diabetic retinopathy screening

Mapping of methods to increase participation in diabetic retinopathy screening Mapping of methods to increase participation in diabetic retinopathy screening - NIPH Search for: Søk Menu To top level Close Infectious diseases & Vaccines Mental & Physical health Environment & Lifestyle Health in Norway Quality & Knowledge Research & Access to data About NIPH Close Mapping of methods to increase participation in diabetic retinopathy screening Subscribe me! You have subscribed to alerts about (...) : Mapping of methods to increase participation in diabetic retinopathy screening Oops, something went wrong... ... contact nettredaksjon@fhi.no. ... reload the page and try again- Mapping review Mapping of methods to increase participation in diabetic retinopathy screening Published 29.10.2020 We have mapped methods to increase screening participation in diabetic retinopathy. We have mapped methods to increase screening participation in diabetic retinopathy. Get alerts about changes Order Download: Key

2021 Norwegian Institute of Public Health

20. Hepatitis B: antenatal screening and selective neonatal immunisation pathway

Hepatitis B: antenatal screening and selective neonatal immunisation pathway Hepatitis B: antenatal screening and selective neonatal immunisation pathway - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check how (...) the new rules affect you Guidance Hepatitis B: antenatal screening and selective neonatal immunisation pathway Guidance on the delivery of antenatal screening and selective neonatal immunisation services for pregnant women living with hepatitis B and their babies. Published 8 January 2021 From: Documents Ref: PHE publications gateway number: GW-1799 HTML Ref: PHE publications gateway number: GW-1799 PDF , 3.16MB , 72 pages This file may not be suitable for users of assistive technology. Request

2021 Public Health England